Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

34.19

-0.48 (-1.38%)

At close: Aug 7, 2025, 4:00 PM

34.25

+0.06 (0.18%)

Pre-market: Aug 8, 2025, 5:24 AM EDT

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Revenue	772.53	714.73	582.02	437.86	305.44	159.74	Upgrade
Revenue Growth (YoY)	17.74%	22.80%	32.93%	43.35%	91.21%	2564.59%	Upgrade
Cost of Revenue	167.33	156.82	121.24	83.48	55.52	27.74	Upgrade
Gross Profit	605.19	557.92	460.79	354.37	249.92	132	Upgrade
Selling, General & Admin	238.58	221.27	192.69	163.3	132.03	95.57	Upgrade
Research & Development	144.75	145.83	76.06	70.89	30.37	19.45	Upgrade
Operating Expenses	383.33	367.09	268.76	234.19	162.39	115.02	Upgrade
Operating Income	221.86	190.83	192.03	120.19	87.53	16.99	Upgrade
Interest Expense	-16.04	-17.5	-23.76	-18.8	-24.19	-28.62	Upgrade
Interest & Investment Income	19.75	18.54	14.73	3.13	0.22	0.4	Upgrade
Other Non Operating Income (Expenses)	-0.43	-0.07	0.16	0.17	0.02	-3.07	Upgrade
EBT Excluding Unusual Items	225.14	191.8	183.16	104.69	63.57	-14.31	Upgrade
Other Unusual Items	-	-	-9.77	-	-26.15	-22.64	Upgrade
Pretax Income	225.14	191.8	173.4	104.69	37.43	-36.94	Upgrade
Income Tax Expense	44.24	46.31	44.54	-76.78	2.83	-	Upgrade
Net Income	180.9	145.49	128.85	181.47	34.6	-36.94	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	-	26.9	Upgrade
Net Income to Common	180.9	145.49	128.85	181.47	34.6	-63.85	Upgrade
Net Income Growth	57.32%	12.91%	-28.99%	424.52%	-	-	Upgrade
Shares Outstanding (Basic)	57	57	59	59	58	26	Upgrade
Shares Outstanding (Diluted)	58	58	60	61	59	26	Upgrade
Shares Change (YoY)	-0.58%	-4.15%	-1.19%	3.19%	129.72%	231.37%	Upgrade
EPS (Basic)	3.16	2.56	2.17	3.07	0.60	-2.48	Upgrade
EPS (Diluted)	3.10	2.51	2.13	2.97	0.58	-2.48	Upgrade
EPS Growth	58.41%	17.84%	-28.28%	412.07%	-	-	Upgrade
Free Cash Flow	258.73	218.67	219.08	144.29	98.26	-2.99	Upgrade
Free Cash Flow Per Share	4.44	3.78	3.63	2.36	1.66	-0.12	Upgrade
Gross Margin	78.34%	78.06%	79.17%	80.93%	81.82%	82.64%	Upgrade
Operating Margin	28.72%	26.70%	32.99%	27.45%	28.66%	10.63%	Upgrade
Profit Margin	23.42%	20.36%	22.14%	41.45%	11.33%	-39.97%	Upgrade
Free Cash Flow Margin	33.49%	30.59%	37.64%	32.95%	32.17%	-1.87%	Upgrade
EBITDA	245.73	214.94	216.39	143.57	106.37	27.22	Upgrade
EBITDA Margin	31.81%	30.07%	37.18%	32.79%	34.83%	17.04%	Upgrade
D&A For EBITDA	23.87	24.11	24.36	23.39	18.84	10.24	Upgrade
EBIT	221.86	190.83	192.03	120.19	87.53	16.99	Upgrade
EBIT Margin	28.72%	26.70%	32.99%	27.45%	28.66%	10.63%	Upgrade
Effective Tax Rate	19.65%	24.14%	25.69%	-	7.56%	-	Upgrade
Advertising Expenses	-	27.56	21.54	22.43	19.56	13.3	Upgrade

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q